Insights

Strategic Acquisitions BTG has recently expanded its portfolio through the acquisition of Penumbra and Valencia Technologies, signaling a focus on cardiovascular and neurovascular markets. This presents opportunities to offer complementary products, services, or technology solutions aligned with their integrated offerings.

Innovation Focus The company's commitment to minimally invasive treatments and development of AI-based diagnostic platforms indicates an openness to cutting-edge medical technology collaborations, making it a target for innovative solutions in diagnostics, medical imaging, and procedural tools.

Market Expansion BTG's active investments and partnerships, including collaborations with AI firms like Anumana, position them as a forward-thinking leader in interventional medicine, creating opportunities to provide advanced tech, clinical support, or expanded product lines in rapidly evolving healthcare segments.

Financial Growth Potential With revenues estimated between $100 million and $250 million and recent high-profile acquisitions, there is potential for increased demand for sales support and tailored healthcare delivery solutions that can enhance their expanded product offerings and market footprint.

Key Personnel & Collaborations The appointment of new executive leaders such as the chief medical officer and CEO indicates ongoing strategic initiatives, providing opportunities to engage decision-makers with targeted solutions that align with their growth and innovation strategies.

BTG plc Tech Stack

BTG plc uses 8 technology products and services including SiteCatalyst, Fastly, SAP SuccessFactors Learning, and more. Explore BTG plc's tech stack below.

  • SiteCatalyst
    Analytics
  • Fastly
    Content Delivery Network
  • SAP SuccessFactors Learning
    Corporate Learning Management Systems
  • SAP Sales and Distribution
    Enterprise Resource Planning
  • .NET
    Programming Languages
  • Google
    Search Engines
  • Tableau Prep
    Visualisation Software
  • Flask
    Web Frameworks

Media & News

BTG plc's Email Address Formats

BTG plc uses at least 2 format(s):
BTG plc Email FormatsExamplePercentage
First.Last@btgplc.comJohn.Doe@btgplc.com
90%
FLast@btgplc.comJDoe@btgplc.com
6%
FirstLast@btgplc.comJohnDoe@btgplc.com
1%
First_Last@btgplc.comJohn_Doe@btgplc.com
2%
FirLast@btgplc.comJohDoe@btgplc.com
1%
First.Last@bostonscientific.comJohn.Doe@bostonscientific.com
76%
FLast@bostonscientific.comJDoe@bostonscientific.com
9%
First_Last@bostonscientific.comJohn_Doe@bostonscientific.com
8%
First@bostonscientific.comJohn@bostonscientific.com
7%

Frequently Asked Questions

Where is BTG plc's headquarters located?

Minus sign iconPlus sign icon
BTG plc's main headquarters is located at 300 Boston Scientific Way Marlborough, Massachusetts 01752 United States. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is BTG plc's phone number?

Minus sign iconPlus sign icon
You can contact BTG plc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BTG plc's stock symbol?

Minus sign iconPlus sign icon
BTG plc is a publicly traded company; the company's stock symbol is GBTG.

What is BTG plc's official website and social media links?

Minus sign iconPlus sign icon
BTG plc's official website is bostonscientific.com and has social profiles on LinkedIn.

How much revenue does BTG plc generate?

Minus sign iconPlus sign icon
As of February 2026, BTG plc's annual revenue is estimated to be $9.1B.

What is BTG plc's SIC code NAICS code?

Minus sign iconPlus sign icon
BTG plc's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does BTG plc have currently?

Minus sign iconPlus sign icon
As of February 2026, BTG plc has approximately 1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Vp Medical Affairs: D. W.President: K. H.President/Producer: P. P.. Explore BTG plc's employee directory with LeadIQ.

What industry does BTG plc belong to?

Minus sign iconPlus sign icon
BTG plc operates in the Medical Equipment Manufacturing industry.

What technology does BTG plc use?

Minus sign iconPlus sign icon
BTG plc's tech stack includes SiteCatalystFastlySAP SuccessFactors LearningSAP Sales and Distribution.NETGoogleTableau PrepFlask.

What is BTG plc's email format?

Minus sign iconPlus sign icon
BTG plc's email format typically follows the pattern of First.Last@btgplc.com. Find more BTG plc email formats with LeadIQ.

How much funding has BTG plc raised to date?

Minus sign iconPlus sign icon
As of February 2026, BTG plc has raised $4.1M in funding. The last funding round occurred on Feb 26, 2016 for $4.1M.

When was BTG plc founded?

Minus sign iconPlus sign icon
BTG plc was founded in 1948.

BTG plc

Medical Equipment ManufacturingMassachusetts, United States1001-5000 Employees

BTG is proud to officially be a part of Boston Scientific

BTG is a global healthcare company focused on Interventional Medicine.  Our innovative medical technology helps physicians treat their patients through minimally invasive procedures.

Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins.

Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare.  As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter.  We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago.  We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems.

With relentless curiosity we’ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.

Section iconCompany Overview

Headquarters
300 Boston Scientific Way Marlborough, Massachusetts 01752 United States
Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
GBTG
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1948
Employees
1001-5000

Section iconFunding & Financials

  • $4.1M

    BTG plc has raised a total of $4.1M of funding over 3 rounds. Their latest funding round was raised on Feb 26, 2016 in the amount of $4.1M.

  • $100M$250M

    BTG plc's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $4.1M

    BTG plc has raised a total of $4.1M of funding over 3 rounds. Their latest funding round was raised on Feb 26, 2016 in the amount of $4.1M.

  • $100M$250M

    BTG plc's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.